Table 3.
Uveal melanoma adjuvant therapy: current trials 1
| Treatment | Status | Results | ClinicalTrials.gov identifier 2 |
|---|---|---|---|
| Sunitinib or valproic acid | not yet recruiting | – | NCT02068586 |
|
| |||
| mRNA (encoding gp100 and tyrosinase)-transfected dendritic cell vaccination | recruiting | no results available | NCT00929019 |
|
| |||
| Dacarbazine and interferon alfa-2b | active, not recruiting | no results available | NCT01100528 |
|
| |||
| Autologous tumor RNA dendritic cell vaccination | not yet recruiting | – | NCT01983748 |
1
Searched with the key words: uveal melanoma, adjuvant. Studies with unknown status were excluded.
2
http://clinicaltrials.gov/ct2/results?term=uveal+melanoma+adjuvant&no_unk=Y. Last accessed: May 1, 2014.